In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation

1:21-md-03017 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Richard G. Andrews
Filed Dec. 10, 2021
Case Flags STAYED, DISCOVERY-LDH, MDL, and PATENT
Magistrate Judge Laura D. Hatcher
Nature of Suit 835 Patent - Abbreviated New Drug Application (ANDA)
Cause 35:271 Patent Infringement
Jury Demand Defendant
Last Updated: 4 hours ago Show Interactive Timeline
Upcoming Events
6 Months
  • 10/18/2025
The stay here expires on approximately October 18, 2025.
Source
Add
Filing Date # Docket Text
3/7/2025Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/7/2025 (nms). (Entered: 03/07/2025)
1/13/2025
  • OrderGranted
SO ORDERED Granting (D.I. 334 in 21-md-3017-RGA-LDH; D.I. 25 in 24-cv-336-RGA) Stipulation and Order of Dismissal regarding Counts I and II of Plaintiffs' Complaint. Signed by Judge Richard G. Andrews on 1/13/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 01/13/2025)
1/9/2025
  • Motion to Dismiss (Demurrer)by Π
STIPULATION of Dismissal with Prejudice as to Counts I and II of Plaintiffs' Complaint against Prinston ('218 Patent) - by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GmbH, Bayer AG. (Fahnestock, Derek) (Entered: 01/09/2025)
11/21/2024
  • OrderGranted
SO ORDERED Granting (D.I. 331 in 21-md-3017-RGA-LDH; D.I. 22 in 24-cv-336-RGA; D.I. 170 in 21-cv-314-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 11/21/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 11/21/2024)
11/21/2024
  • OrderGranted
SO ORDERED Granting (D.I. 21 in 24-cv-336-RGA; D.I. 330 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/21/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 11/21/2024)
11/21/2024
  • Motion to Consolidateby Π
STIPULATION and [Proposed] Order Regarding Consolidation and Schedule (as to Defendant Prinston Pharmaceutical, Inc., C.A. 24-336) - by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG. (Fahnestock, Derek) (Entered: 11/21/2024)
11/21/2024
  • Motionby Π
STIPULATION and [Proposed] Order Regarding Infringement - by Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG. (Fahnestock, Derek) (Entered: 11/21/2024)
11/19/2024Pro Hac Vice Attorney Gwen Hochman Stewart for Janssen Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:21-cv-01742-RGA, 1:23-cv-00410-RGA, 1:24-cv-00336-RGA(cdd) (Entered: 11/19/2024)
11/19/2024
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 328 MOTION for Pro Hac Vice Appearance of Attorney Gwen Hochman Stewart, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 11/19/2024. (aas) (Entered: 11/19/2024)
11/19/2024329Pro Hac Vice Fee - Credit Card Payment received for Gwen Hochman Stewart. ( re 328 MOTION for Pro Hac Vice Appearance of Attorney Gwen Hochman Stewart )( Payment of $ 50, receipt number ADEDC-4551926).(Fahnestock, Derek) (Entered: 11/19/2024)
11/19/2024
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Gwen Hochman Stewart - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/19/2024)
11/5/2024
  • Motion to Dismiss (Demurrer)Granted
SO ORDERED Granting Stipulation of Dismissal (D.I. 326 in 21-md-3017-RGA-LDH; D.I. 18 in 24-cv-588-RGA) (*Hetero Labs Limited and Ascent Pharmaceuticals Inc. terminated). Signed by Judge Richard G. Andrews on 11/5/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00588-RGA(nms) (Entered: 11/05/2024)
11/5/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal with prejudice as to Defendants Ascent Pharmaceuticals Inc. and Hetero Labs Limited (C.A. 24-588), by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/5/2024 (nms). (Entered: 11/05/2024)
10/25/2024
  • Motion to Dismiss (Demurrer)Granted
SO ORDERED Granting 324 Stipulation of Dismissal (*Auson Pharmaceuticals, Inc. and Shanghai Auson Pharmaceuticals Co. Ltd. terminated). Signed by Judge Richard G. Andrews on 10/25/2024. (nms) (Entered: 10/25/2024)
10/24/2024
  • Motion to Dismiss (Demurrer)by Π
STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 10/24/2024)
10/24/2024
  • Motion to Extend Time
SO ORDERED, re 323 STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 11/6/2024). Signed by Judge Richard G. Andrews on 10/24/2024. (nms) (Entered: 10/24/2024)
10/23/2024
  • Motion to Extend Time
STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/24/2024 (nms). (Entered: 10/23/2024)
10/22/2024REDACTED VERSION of 318 Stipulation, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 10/22/2024 (nms). (Entered: 10/22/2024)
10/16/2024
  • Motion to ConsolidateGranted
SO ORDERED Granting Stipulation and Order Regarding Consolidation and Schedule (D.I. 319 in 21-md-3017-RGA-LDH; D.I. 27 in 23-cv-1219-RGA; D.I. 166 in 21-cv-314-RGA-LDH). Signed by Judge Richard G. Andrews on 10/16/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 10/16/2024)
10/16/2024
  • Motion to StayGranted
[SEALED] ORDER Granting Stipulation and Proposed Order to Stay (*Set Deadlines: Status Report due by 11/15/2024). Signed by Judge Richard G. Andrews on 10/16/2024.This order has been emailed to local counsel. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 10/16/2024)
10/15/2024 STIPULATION and Order Regarding Consolidation and Schedule (as to Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 10/15/2024)
10/15/2024
  • Motion to Stayby Π
[SEALED] STIPULATION and [Proposed] Order to Stay - by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 10/15/2024)
10/11/2024
  • Answer
ANSWER to 287 Answer to Complaint and Counterclaims of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc., filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) Modified on 10/11/2024 (nms). (Entered: 10/11/2024)
10/8/2024
  • Motion to Extend Time
SO ORDERED, re 316 STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 10/23/2024). Signed by Judge Richard G. Andrews on 10/8/2024. (nms) (Entered: 10/08/2024)
10/8/2024
  • Motion to Extend Time
STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/8/2024 (nms). (Entered: 10/08/2024)
10/4/2024NOTICE of Voluntary Dismissal by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. as to U.S. Patent 9,415,053 Counterclaims (Vrana, Robert) (Entered: 10/04/2024)
9/27/2024
  • Motion to Extend Time
SO ORDERED, re 314 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries, Ltd. answer due 10/11/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 10/11/2024). Signed by Judge Richard G. Andrews on 9/27/2024. (nms) (Entered: 09/27/2024)
9/27/2024 STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/27/2024 (nms). (Entered: 09/27/2024)
9/24/2024
  • Motion to Extend Time
SO ORDERED, re 313 STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 10/9/2024). Signed by Judge Richard G. Andrews on 9/24/2024. (nms) (Entered: 09/24/2024)
9/24/2024
  • Motion to Extend Time
STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 9/24/2024 (nms). (Entered: 09/24/2024)
9/24/2024REDACTED VERSION of 309 Stipulation, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 9/24/2024 (nms). (Entered: 09/24/2024)
9/19/2024REDACTED VERSION of 297 Notice to Take Deposition, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 9/19/2024 (nms). (Entered: 09/19/2024)
9/19/2024SECOND REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 297 . (nms) (Entered: 09/19/2024)
9/17/2024
  • Motion to StayGranted
[SEALED] ORDER Granting Stipulation and Proposed Order to Stay (D.I. 69 in 23-cv-1103-RGA; D.I. 309 in 21-md-3017-RGA-LDH). Signed by Judge Richard G. Andrews on 9/17/2024.This order has been emailed to local counsel. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 09/17/2024)
9/17/2024
  • Motion to Stay
[SEALED] Stipulation and [Proposed] Order to Stay, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 9/17/2024 (nms). (Entered: 09/17/2024)
9/16/2024REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI # 297 . (nms) (Entered: 09/16/2024)
9/13/2024NOTICE OF SERVICE of Defendants Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.'s Sur-Reply Claim Construction Brief filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/13/2024)
9/12/2024
  • Motion to Extend Time
SO ORDERED, re 307 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 9/27/2024; Bayer Pharma AG answer due 9/27/2024; Janssen Pharmaceuticals, Inc. answer due 9/27/2024). Signed by Judge Richard G. Andrews on 9/12/2024. (nms) (Entered: 09/12/2024)
9/12/2024 STIPULATION and Proposed Order to Extend Time to respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Complaint - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/12/2024 (nms). (Entered: 09/12/2024)
9/6/2024NOTICE to Take Deposition of Klaus Wehling on October 24, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Alexander Straub on October 23, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Karl Heinz Schlemmer on October 21, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Elizabeth Perzborn on October 22, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Son-Mi Park on October 29, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Frank Misselwitz on October 25, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Dagmar Kubitza on October 28, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024NOTICE to Take Deposition of Klaus Benke on October 30, 2024 filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 09/06/2024)
9/6/2024Joint Status Report Regarding Stay, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc., Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 9/6/2024 (nms). (Entered: 09/06/2024)
9/5/2024[SEALED] NOTICE to Take Deposition of Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Smith, Rodger) (Entered: 09/05/2024)
9/3/2024NOTICE OF SERVICE of Plaintiffs' Second Set of Interrogatories to Defendants Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd. filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 09/03/2024)
8/30/2024NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 08/30/2024)
8/27/2024CORRECTING ENTRY: The SO ORDERED entry for 8/27/2024, has been corrected to reflect Plaintiffs' answer due date is being reset. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 08/27/2024)
8/27/2024
  • Motion to Extend Time
SO ORDERED, re 294 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 9/13/2024; Bayer Pharma AG answer due 9/13/2024; Janssen Pharmaceuticals, Inc. answer due 9/13/2024). Signed by Judge Richard G. Andrews on 8/27/2024. (nms) (Entered: 08/27/2024)
8/27/2024 STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/27/2024 (nms). (Entered: 08/27/2024)
8/23/2024
  • Motion to Extend Time
SO ORDERED, re 293 STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 9/25/2024). Signed by Judge Richard G. Andrews on 8/23/2024. (nms) (Entered: 08/23/2024)
8/23/2024
  • Motion to Extend Time
STIPULATION to Extend Time to respond to the Complaint to September 25, 2024 - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 8/23/2024 (nms). (Entered: 08/23/2024)
8/19/2024
  • Answer
Answer to Counterclaims of Defendant Prinston Pharmaceutical, Inc., by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/20/2024 (nms). (Entered: 08/19/2024)
8/16/2024NOTICE OF SERVICE of Defendants Auson Pharmaceuticals Inc.s and Shanghai Auson Pharmaceuticals Co., Ltd.s Answering Claim Construction brief re 285 Notice of Service filed by Auson Pharmaceuticals, Inc..(DeSantis, Kasey) (Entered: 08/16/2024)
8/12/2024
  • Order
SO ORDERED, re (D.I. 290 in 21-md-3017-RGA-LDH; D.I. 13 in 24-cv-588-RGA) STIPULATION to Extend Time to respond to the Complaint to August 26, 2024. Signed by Judge Richard G. Andrews on 8/12/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00588-RGA(nms) (Entered: 08/12/2024)
8/12/2024
  • Motion to Extend Time
STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 8/12/2024 (nms). (Entered: 08/12/2024)
8/9/2024 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alkaloida Chemical Co. ZRT for Taro Pharmaceutical Industries Ltd.; Other Affiliate Sun Pharmaceutical Industries Ltd., Other Affiliate Taro Pharmaceuticals Industries Ltd. for Taro Pharmaceuticals U.S.A., Inc. filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) (Entered: 08/09/2024)
8/9/2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 . (Gaza, Anne) (Entered: 08/09/2024)
8/9/2024
  • Answer
ANSWER to Complaint and COUNTERCLAIMS against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Attachments: # 1 Exhibit 1)(Gaza, Anne) Modified on 8/12/2024 (nms). (Entered: 08/09/2024)
7/30/2024
  • Answer
ANSWER to Complaint with Jury Demand and COUNTERCLAIMs against Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Prinston Pharmaceutical, Inc..(Gattuso, Dominick) Modified on 7/31/2024 (nms). (Entered: 07/30/2024)
7/26/2024NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 07/26/2024)
7/26/2024
  • Motion to Extend Time
SO ORDERED, re 284 Stipulation and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries, Ltd. answer due 8/9/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 8/9/2024; Teva Pharmaceutical Industries Ltd answer due 8/9/2024; Teva Pharmaceuticals USA, Inc. answer due 8/9/2024). Signed by Judge Richard G. Andrews on 7/26/2024. (nms) (Entered: 07/26/2024)
7/26/2024 STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) Modified on 7/26/2024 (nms). (Entered: 07/26/2024)
7/25/2024
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 283 MOTION for Pro Hac Vice Appearance of Attorney Theresa Starck, filed by Xarelto (Rivaroxaban) ('310) Patent Litigation. Signed by Judge Richard G. Andrews on 7/25/2024. (nms) (Entered: 07/25/2024)
7/25/2024
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Theresa Starck - filed by Xarelto (Rivaroxaban) ('310) Patent Litigation. (Gattuso, Dominick) (Entered: 07/25/2024)
7/25/2024282Pro Hac Vice Fee - Credit Card Payment received for Theresa Starck. ( Payment of $ 50, receipt number ADEDC-4460405).(Gattuso, Dominick) (Entered: 07/25/2024)
7/11/2024
  • Motion to Extend Time
SO ORDERED, re 281 STIPULATION and Order to Extend Time for Prinston Pharmaceutical, Inc. to answer by July 29, 2024. Signed by Judge Richard G. Andrews on 7/11/2024. (nms) (Entered: 07/11/2024)
7/11/2024 STIPULATION and Order to Extend Time - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 7/11/2024 (nms). (Entered: 07/11/2024)
7/11/2024 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ascent Pharmaceuticals Inc.. (Hitch, Cortlan) (Entered: 07/11/2024)
7/11/2024
  • Answer
ANSWER to Complaint by Ascent Pharmaceuticals Inc..(Hitch, Cortlan) (Entered: 07/11/2024)
7/10/2024
  • Motion to Extend Time
SO ORDERED, re 278 STIPULATION to Extend Time to respond to the Complaint to August 12, 2024. Signed by Judge Richard G. Andrews on 7/10/2024. (nms) (Entered: 07/10/2024)
7/10/2024
  • Motion to Extend Time
STIPULATION to Extend Time to respond to the Complaint to August 12, 2024 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/10/2024 (nms). (Entered: 07/10/2024)
7/3/2024JOINT Claim Construction Chart, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Chart 1, # 2 Exhibit A, # 3 Exhibit B part 1, # 4 Exhibit B part 2, # 5 Exhibit B part 3, # 6 Exhibit B part 4)(Fahnestock, Derek) Modified on 7/3/2024 (nms). (Entered: 07/03/2024)
7/1/2024
  • Motion to Extend Time
SO ORDERED, re 276 STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/1/2024. (nms) (Entered: 07/01/2024)
6/28/2024 STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 7/1/2024 (nms). (Entered: 06/28/2024)
6/21/2024
  • OrderGranted
SO ORDERED Granting (D.I. 51 in 23-cv-1103-RGA; D.I. 274 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Claim Construction Deadlines (*Reset Deadlines: Joint Claim Construction Brief due by 9/18/2024). Signed by Judge Richard G. Andrews on 6/21/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 06/21/2024)
6/20/2024 STIPULATION and Proposed Order to Extend Claim Construction Deadlines - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 6/21/2024 (nms). (Entered: 06/20/2024)
6/20/2024273
  • Order
ORAL ORDER: At the request of the parties and due to religious observances the Markman Hearing scheduled for 10/3/2024, is CANCELED. The Markman hearing is now rescheduled for 10/11/2024, at 9:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 6/20/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 06/20/2024)
6/6/2024
  • Order
SO ORDERED, re (D.I. 13 in 24-cv-336-RGA: D.I. 272 in 21-md-3017-RGA-LDH) STIPULATION and Order to Extend Time to answer, move or otherwise respond to the complaint is to July 15, 2024. Signed by Judge Richard G. Andrews on 6/6/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 06/06/2024)
6/6/2024 STIPULATION and Order to Extend Time to answer, move or otherwise respond to the complaint is to July 15, 2024 - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 6/6/2024 (nms). (Entered: 06/06/2024)
5/29/2024
  • Order
SO ORDERED, re (D.I. 16 in 23-cv-1219-RGA; D.I. 271 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to June 28, 2024. Signed by Judge Richard G. Andrews on 5/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 05/29/2024)
5/29/2024 STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 5/29/2024 (nms). (Entered: 05/29/2024)
5/28/2024CORRECTING ENTRY: The Notice of Service (D.I. 271 in 21md3017-RGA; D.I. 50 in 23cv1103-RGA) filed on 5/24/2024, has been removed as it was duplicative of a a notice of service already on the docket. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 05/28/2024)
5/24/2024NOTICE OF SERVICE of Defendants List of Claim Terms, Phrases and Proposed Constructions filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 05/24/2024)
5/24/2024NOTICE OF SERVICE of Plaintiffs' Proposed Claim Terms for Construction - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 05/24/2024)
5/10/2024
  • OrderGranted
SO ORDERED Granting (D.I. 20 in 23-cv-1372-RGA; D.I. 267 in 21-md-03017-RGA-LDH) Stipulation of Dismissal (*Party Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited terminated). Signed by Judge Richard G. Andrews on 5/10/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01372-RGA(nms) (Entered: 05/10/2024)
5/10/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal as to Defendants Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. with prejudice, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/10/2024 (nms). (Entered: 05/10/2024)
5/9/2024
  • Order
SO ORDERED, re (D.I. 10 in 24-cv-336-RGA; D.I. 264 in 21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos, filed by Prinston Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 5/9/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 05/09/2024)
5/9/2024266Pro Hac Vice Fee - Credit Card Payment received for William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron, and Steven J. Birkos. ( re 264 MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos )( Payment of $ 200, receipt number ADEDC-4403357).(Gattuso, Dominick) (Entered: 05/09/2024)
5/8/2024 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Zhejiang Huahai Pharmaceutical Co. Ltd for Prinston Pharmaceutical, Inc. filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 05/08/2024)
5/8/2024
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney William A. Rakoczy, Lara E. FitzSimmons, Rachel Pernic Waldron and Steven J. Birkos - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) (Entered: 05/08/2024)
5/3/2024NOTICE OF SERVICE of Defendant and Counterclaimant Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Initial Invalidity Contentions and Initial Invalidity Contentions Exhibits filed by Auson Pharmaceuticals, Inc., Shanghai Auson Pharmaceuticals Co. Ltd..(DeSantis, Kasey) (Entered: 05/03/2024)
5/2/2024
  • Order
SO ORDERED, re (D.I. 262 in 21-md-3017-RGA-LDH; D.I. 9 in 24-cv-336-RGA) STIPULATION and Order to extend time to answer, move or otherwise respond to the complaint to June 13, 2024. Signed by Judge Richard G. Andrews on 5/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:24-cv-00336-RGA(nms) (Entered: 05/02/2024)
5/2/2024 STIPULATION and Order to extend time to answer, move or otherwise respond to the complaint to June 13, 2024 - filed by Prinston Pharmaceutical, Inc.. (Gattuso, Dominick) Modified on 5/2/2024 (nms). (Entered: 05/02/2024)
4/29/2024
  • Order
SO ORDERED, re (D.I. 15 in 23-cv-1219-RGA; D.I. 261 in 21-md-3017-RGA-LDH) STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to May 29, 2024. Signed by Judge Richard G. Andrews on 4/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 04/29/2024)
4/29/2024 STIPULATION and Proposed Order to Extend Time to answer, move or otherwise respond to the Complaint to May 29, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 4/29/2024 (nms). (Entered: 04/29/2024)
4/29/2024
  • OrderGranted
SO ORDERED Granting (D.I. 259 in 21-md-03017-RGA-LDH; D.I. 46 in 23-cv-01103-RGA) Stipulation and Proposed Order correcting defendant name. Signed by Judge Richard G. Andrews on 4/29/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 04/29/2024)
4/29/2024
  • Motionby Π
STIPULATION and [Proposed] Order to Correct Case Caption - by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 04/29/2024)
4/9/2024
  • Answer
Answer to Complaint and Counterclaims (D.I. 10 in 24-cv-138-RGA; D.I. 10 in 24-cv-138-RGA), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/10/2024 (nms). (Entered: 04/09/2024)
4/5/2024NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Auson's NDA Products - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 04/05/2024)
4/2/2024
  • OrderGranted
SO ORDERED Granting (D.I. 162 in 21-cv-314-RGA-LDH; D.I. 13 in 24-cv-138-RGA; D.I. 255 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 4/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:24-cv-00138-RGA(nms) (Entered: 04/02/2024)
4/1/2024 STIPULATION and Order Regarding Consolidation and Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 04/01/2024)
3/28/2024
  • Motion to Extend Time
SO ORDERED, re 254 STIPULATION and Proposed Order to Extend Time. (*Reset Answer Deadlines: Taro Pharmaceutical Industries, Ltd. answer due 4/29/2024; Taro Pharmaceuticals U.S.A., Inc. answer due 4/29/2024). Signed by Judge Richard G. Andrews on 3/28/2024. (lah) (Entered: 03/28/2024)
3/28/2024 STIPULATION and Proposed Order to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) Modified on 3/28/2024 (nms). (Entered: 03/28/2024)
3/27/2024
  • OrderGranted
SO ORDERED Granting (D.I. 252 in 21-md-3017-RGA-LDH; D.I. 10 in 23-cv-1456-RGA) Stipulation of Dismissal (*Party Umedica Laboratories Pvt. Ltd. and Umedica Laboratories Pvt. Ltd. terminated). Signed by Judge Richard G. Andrews on 3/27/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01456-RGA(nms) (Entered: 03/27/2024)
3/27/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal as to Defendant Umedica Laboratories Pvt, Ltd., filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/27/2024 (nms). (Entered: 03/27/2024)
3/25/2024NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Responses and Objections to Defendants' First Set of Requests for Production to Plaintiffs; (2) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Responses and Objections to Defendants' First Set of Interrogatories to Plaintiffs; (3) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Requests for Production to Plaintiffs; and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Interrogatories to Plaintiffs - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 03/25/2024)
3/22/2024Pro Hac Vice Attorney Jonathan J. Madara for Auson Pharmaceuticals Co., Ltd. and Auson Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/22/2024)
3/22/2024
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 249 MOTION for Pro Hac Vice Appearance of Attorney Jonathan J. Madara, filed by Auson Pharmaceuticals, Inc., Auson Pharmaceuticals Co., Ltd.. Signed by Judge Richard G. Andrews on 3/22/2024. (nms) (Entered: 03/22/2024)
3/21/2024250Pro Hac Vice Fee - Credit Card Payment received for Jonathan J. Madara. ( re 249 MOTION for Pro Hac Vice Appearance of Attorney Jonathan J. Madara )( Payment of $ 50, receipt number ADEDC-4367769).(DeSantis, Kasey) (Entered: 03/21/2024)
3/21/2024
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Jonathan J. Madara - filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc.. (DeSantis, Kasey) (Entered: 03/21/2024)
3/19/2024NOTICE of Appearance by Megan C. Haney on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Haney, Megan) (Entered: 03/19/2024)
3/19/2024 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) (Entered: 03/19/2024)
3/19/2024
  • Answer
ANSWER to Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by Lupin Pharmaceuticals, Inc., Lupin Limited.(Haney, Megan) Modified on 3/19/2024 (nms). (Entered: 03/19/2024)
3/14/2024NOTICE OF SERVICE of Defendant and Counterclaimant Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Objections and Responses to Plaintiffs' Discovery Requests, filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc..(DeSantis, Kasey) Modified on 3/15/2024 (nms). (Entered: 03/14/2024)
3/11/2024NOTICE OF SERVICE of Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd.s samples and core technical documents filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc..(DeSantis, Kasey) (Entered: 03/11/2024)
3/8/2024Joint Status Report Regarding Stay, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/11/2024 (nms). (Entered: 03/08/2024)
3/6/2024
  • OrderGranted
SO ORDERED Granting Stipulated Protective Order (D.I. 37 in 23-cv-1103-RGA; D.I. 241 in 21-md-3017-RGA-LDH). Signed by Judge Richard G. Andrews on 3/6/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 03/06/2024)
3/6/2024 PROPOSED Stipulated Protective Order, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 3/6/2024 (nms). (Entered: 03/06/2024)
3/4/2024Pro Hac Vice Attorneys Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan for Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/04/2024)
3/1/2024
  • Order
SO ORDERED, re (D.I. 18 in 23-cv-1372-RGA; D.I. 239 in 21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan, filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 3/1/2024. Associated Cases: 1:23-cv-01372-RGA, 1:21-md-03017-RGA-LDH(nms) (Entered: 03/01/2024)
3/1/2024240Pro Hac Vice Fee - Credit Card Payment received for Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan. ( re 239 MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan )( Payment of $ 150, receipt number CDEDC-4351265).(Myer, R.) (Entered: 03/01/2024)
2/29/2024
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Timothy H. Kratz, George J. Barry, III, and Michael P. Hogan - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) (Entered: 02/29/2024)
2/27/2024NOTICE OF SERVICE of (i) Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (ii) Auson Pharmaceuticals Inc. and Shanghai Auson Pharmaceuticals Co., Ltd.s Initial Disclosures Identifying Custodians and Non-Custodial Sources filed by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc..(DeSantis, Kasey) (Entered: 02/27/2024)
2/27/2024
  • Motion to Extend Time
SO ORDERED, re 237 STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to March 28, 2024. Signed by Judge Richard G. Andrews on 2/27/2024. (nms) (Entered: 02/27/2024)
2/27/2024
  • Motion to Extend Time
STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to March 28, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 2/27/2024 (nms). (Entered: 02/27/2024)
2/27/2024NOTICE OF SERVICE of (1) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Initial Disclosures; (2) Bayer Intellectual Property GmbH, Bayer Pharma AG, and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery; (3) Janssen Pharmaceuticals, Inc.'s Initial Disclosures; and (4) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware's Default Standard for Discovery - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 02/27/2024)
2/27/2024
  • OrderGranted
SO ORDERED Granting (D.I. 233 in 21-md-3017-RGA-LDH; D.I. 15 in 23-cv-327-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Apotex Inc. and Apotex Corp.. Signed by Judge Richard G. Andrews on 2/27/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00327-RGA(nms) (Entered: 02/27/2024)
2/27/2024
  • OrderGranted
SO ORDERED Granting (D.I. 18 in 23-cv-690-RGA; D.I. 232 in 21-md-3017-RGA-LDH) Stipulation of Dismissal between Plaintiffs and Defendants Indoco Remedies Limited and FPP Holding Company, LLC. Signed by Judge Richard G. Andrews on 2/27/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00690-RGA(nms) (Entered: 02/27/2024)
2/27/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal between Plaintiffs and Defendants Apotex Inc. and Apotex Corp., by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/27/2024 (nms). (Entered: 02/27/2024)
2/27/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal, by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/27/2024 (nms). (Entered: 02/27/2024)
2/26/2024 NOTICE of of Service of Defendants' First Set of Requests for Production (Nos. 1-80) and Defendants' First Set of Interrogatories (Nos. 1-7) to Plaintiffs Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. by Auson Pharmaceuticals Co., Ltd., Auson Pharmaceuticals, Inc. (DeSantis, Kasey) (Entered: 02/26/2024)
2/23/2024NOTICE OF SERVICE of Production of Defendants' Core Technical Documents Pursuant to Paragraph 4(b) of the Delaware Default Standard for Discovery and Pursuant to the Standing Order Regarding Hatch-Waxman Cases in Which Infringement is Alleged filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Myer, R.) (Entered: 02/23/2024)
2/23/2024 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) (Entered: 02/23/2024)
2/23/2024
  • Answerby Δ
ANSWER to Complaint by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc..(Myer, R.) (Entered: 02/23/2024)
2/20/2024
  • Order
SO ORDERED, re (D.I. 32 in 23-cv-1103-RGA; D.I. 226 in 21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney Richard Hildreth III and Dana B. Kinel, filed by Bayer Pharma AG, Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 2/20/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 02/20/2024)
2/16/2024227Pro Hac Vice Fee - Credit Card Payment received for Richard Hildreth III and Dana B. Kinel. ( re 226 MOTION for Pro Hac Vice Appearance of Attorney Richard Hildreth III and Dana B. Kinel )( Payment of $ 100, receipt number ADEDC-4341232).(Fahnestock, Derek) (Entered: 02/16/2024)
2/16/2024
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Richard Hildreth III and Dana B. Kinel - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 02/16/2024)
2/16/2024
  • Order
SO ORDERED, re (D.I. 30 in 23-cv-1103-RGA; D.I. 224 in 1:21-md-3017-RGA-LDH) MOTION for Pro Hac Vice Appearance of Attorney Ben Picozzi, filed by Bayer Pharma AG, Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 2/16/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 02/16/2024)
2/16/2024225Pro Hac Vice Fee - Credit Card Payment received for Ben Picozzi. ( re 224 MOTION for Pro Hac Vice Appearance of Attorney Ben Picozzi )( Payment of $ 50, receipt number ADEDC-4341126).(Fahnestock, Derek) (Entered: 02/16/2024)
2/16/2024
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Ben Picozzi - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 02/16/2024)
2/15/2024223
  • Motion to Extend Time
SO ORDERED, re 222 STIPULATION to Further Extend Time. Signed by Judge Richard G. Andrews on 2/15/2024. (nms) (Entered: 02/15/2024)
2/15/2024
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for Defendants to answer, move or otherwise respond to the Complaint to February 29, 2024 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 02/15/2024)
2/14/2024NOTICE OF SERVICE of (1) Plaintiffs' First Set of Requests for Production to Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd.; and (2) Plaintiffs' First Set of Interrogatories to Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd. - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Smith, Rodger) (Entered: 02/14/2024)
2/12/2024
  • Scheduling Order
SCHEDULING ORDER: Joinder of Parties due by 8/23/2024. Amended Pleadings due by 8/23/2024. Fact Discovery completed by 11/1/2024. Joint Claim Construction Brief due by 9/11/2024. A Markman Hearing is set for 10/3/2024, at 9:30 AM in Courtroom 6A. Within seven days of March 14, 2025, the parties shall submit a Joint Status Report to the Court addressing remand of the action to the District of New Jersey for trial proceedings (see Order for further details). Signed by Judge Richard G. Andrews on 2/12/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 02/12/2024)
2/9/2024NOTICE OF SERVICE of Bayer Intellectual Property GmbH, Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 02/09/2024)
2/6/2024
  • Motion to Extend Time
SO ORDERED, re 217 STIPULATION to Extend Time. Signed by Judge Richard G. Andrews on 2/6/2024. (nms) (Entered: 02/06/2024)
2/6/2024 PROPOSED Scheduling Order, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 2/6/2024 (nms). (Entered: 02/06/2024)
2/6/2024
  • Motion to Extend Time
STIPULATION to Extend Time - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 2/6/2024 (nms). (Entered: 02/06/2024)
2/6/2024
  • Answer
Answer to Complaint and Counterclaims of Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd., filed by Bayer Intellectual Property GMBH. (Fahnestock, Derek) Modified on 2/6/2024 (nms). (Entered: 02/06/2024)
2/5/2024
  • Motion to Extend Time
SO ORDERED, re 215 STIPULATION for Extension of Time to Answer, Move or Otherwise Respond to Complaint to February 23, 2024. Signed by Judge Richard G. Andrews on 2/5/2024. (nms) (Entered: 02/05/2024)
2/5/2024
  • Motion to Extend Time
STIPULATION for Extension of Time to Answer, Move or Otherwise Respond to Complaint to February 23, 2024 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) Modified on 2/5/2024 (nms). (Entered: 02/05/2024)
2/1/2024
  • Motion to Extend Time
SO ORDERED, re 214 Unopposed Motion to Extend Time, filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG, Bayer Intellectual Property GMBH. Signed by Judge Richard G. Andrews on 2/1/2023. (nms) (Entered: 02/01/2024)
1/31/2024
  • Motion to Extend Time
Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/1/2024 (nms). (Entered: 01/31/2024)
1/31/2024
  • Motion to Extend Time
SO ORDERED, re 213 STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to February 15, 2024. Signed by Judge Richard G. Andrews on 1/31/2024. (nms) (Entered: 01/31/2024)
1/31/2024
  • Motion to Extend Time
STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to February 15, 2024 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/31/2024 (nms). (Entered: 01/31/2024)
1/26/2024
  • Order
SO ORDERED, re (D.I. 212 in 21-md-3017-RGA-LDH; D.I. 13 in 23-cv-1372-RGA) STIPULATION for Extension of Time to Answer, Move or Otherwise Respond to Complaint to February 9, 2024. Signed by Judge Richard G. Andrews on 1/26/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01372-RGA(nms) (Entered: 01/26/2024)
1/26/2024
  • Motion to Extend Time
STIPULATION for Extension of Time to Answer, Move or Otherwise Respond to Complaint to February 9, 2024 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA Inc.. (Myer, R.) Modified on 1/26/2024 (nms). (Entered: 01/26/2024)
1/25/2024
  • OrderGranted
SO ORDERED Granting (D.I. 210 in 21-md-3017-RGA-LDH; D.I. 17 in 23-cv-665-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 1/25/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00665-RGA(nms) (Entered: 01/25/2024)
1/25/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal between Plaintiffs and Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. with prejudice - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 1/25/2024 (nms). (Entered: 01/25/2024)
1/18/2024NOTICE of Appearance by Anne Shea Gaza on behalf of Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (Gaza, Anne) (Entered: 01/18/2024)
1/17/2024
  • Order
SO ORDERED, re (D.I. 208 in 21-md-3017-RGA-LDH; D.I. 10 in 23-cv-1219-RGA) STIPULATION to Extend Time to answer, move, or otherwise respond to the Complaint to February 6, 2024. Signed by Judge Richard G. Andrews on 1/17/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01219-RGA(nms) (Entered: 01/17/2024)
1/16/2024
  • Motion to Extend Time
STIPULATION to Extend Time to answer, move, or otherwise respond to the Complaint to February 6, 2024 - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) Modified on 1/17/2024 (nms). (Entered: 01/16/2024)
1/2/2024
  • Order
SO ORDERED, re (D.I. 207 in 21-md-3017-RGA-LDH; D.I. 15 in 23-cv-690-RGA) STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to February 1, 2024. Signed by Judge Richard G. Andrews on 1/2/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00690-RGA(nms) (Entered: 01/02/2024)
1/2/2024
  • Motion to Extend Time
STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to February 1, 2024 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/2/2024 (nms). (Entered: 01/02/2024)
12/22/2023NOTICE requesting Clerk to remove Elham Firouzi Steiner as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Moore, David) (Entered: 12/22/2023)
12/21/2023205
  • Motion to Stay
ORAL ORDER: The Stay as to the '218 patent is LIFTED. The parties should propose a schedule that results in remand of at least the '218 patent to New Jersey so that the case is ready to be tried before October 2025. Ordered by Judge Richard G. Andrews on 12/21/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01103-RGA(nms) (Entered: 12/21/2023)
12/15/2023 Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock regarding, status. (Fahnestock, Derek) Modified on 12/18/2023 (nms). (Entered: 12/15/2023)
12/15/2023
  • OrderGranted
SO ORDERED Granting (D.I.158 in 21-cv-314-RGA-LDH; D.I. 14 in 23-cv-1196-RGA; D.I. 202 in 21-md-3017-RGA-LDH) Stipulation and Order Regarding Consolidation and Schedule: Civil Action 23-1196-RGA is consolidated with Civil Action 21 314-RGA-JLH for all purposes, including for trial. All papers shall be filed in Civil Action 21-314-RGA-JLH (see Order for further details). Signed by Judge Richard G. Andrews on 12/15/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:21-cv-00314-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 12/15/2023)
12/15/2023
  • Motion to Consolidate
STIPULATION and [Proposed] Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/15/2023 (nms). (Entered: 12/15/2023)
12/14/2023
  • Order
SO ORDERED, re (D.I. 201 in 21-md-3017-RGA-LDH; D.I. 13 in 23-cv-1196-RGA) STIPULATION Extending Time to Respond to Complaint to December 22, 2023. Signed by Judge Richard G. Andrews on 12/14/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 12/14/2023)
12/13/2023
  • Motion to Extend Time
STIPULATION Extending Time to Respond to Complaint to December 22, 2023 - filed by Cipla Ltd., Cipla USA Inc., Invagen Pharmaceuticals, Inc.. (Ferraro, April) Modified on 12/14/2023 (nms). (Entered: 12/13/2023)
12/4/2023Pro Hac Vice Attorneys A. Neal Seth and Teresa M. Summers for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00665-RGA(mpb) (Entered: 12/04/2023)
12/1/2023
  • Order
SO ORDERED, re (D.I. 14 in 23-cv-690-RGA; D.I. 200 in 21-md-3017-RGA-LDH) STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to January 2, 2024. Signed by Judge Richard G. Andrews on 12/1/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00690-RGA(nms) (Entered: 12/01/2023)
12/1/2023
  • Motion to Extend Time
STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to January 2, 2024 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/1/2023 (nms). (Entered: 12/01/2023)
12/1/2023
  • Order
SO ORDERED, re (D.I. 199 in 21-md-3017-RGA-LDH; D.I. 16 in 23-cv-665-RGA) MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth and Teresa M. Summers of Wiley Rein, L.L.P., filed by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 12/1/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00665-RGA(nms) (Entered: 12/01/2023)
11/30/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth and Teresa M. Summers of Wiley Rein, L.L.P. - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: # 1 Certification of A. Neal Seth, # 2 Certification of Teresa M. Summers, # 3 Text of Proposed Order)(Seaman, John) (Entered: 11/30/2023)
11/21/2023
  • OrderGranted
SO ORDERED Granting (D.I. 197 in 21-md-3017-RGA-LDH; D.I. 11 in 23-cv-1196-RGA) Stipulation and Proposed Order Joining Invagen Pharmaceuticals, Inc. (Invagen Pharmaceuticals, Inc. added). Signed by Judge Richard G. Andrews on 11/21/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 11/21/2023)
11/20/2023 STIPULATION and [Proposed] Order Joining Invagen Pharmaceuticals, Inc. by Cipla Ltd., Cipla USA Inc.. (Ferraro, April) (Entered: 11/20/2023)
11/7/2023
  • Order
SO ORDERED, re (D.I. 10 in 23-cv-1196-RGA; D.I. 196 in 21-md-3017-RGA-LDH) STIPULATION to Extend Time for Cipla Ltd and Cipla USA Inc. to answer, move, or otherwise respond to the Complaint in this action to December 14, 2023. Signed by Judge Richard G. Andrews on 11/7/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-01196-RGA(nms) (Entered: 11/07/2023)
11/7/2023
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for Defendants Cipla Ltd and Cipla USA Inc. to answer, move, or otherwise respond to the Complaint in this action (D.I. 1) to December 14, 2023 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/07/2023)
11/1/2023
  • Order
SO ORDERED, re (D.I. 195 in 21-md-3017-RGA-LDH; D.I. 13 in 23-cv-690-RGA) STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to December 1, 2023. Signed by Judge Richard G. Andrews on 11/1/2023. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00690-RGA(nms) (Entered: 11/01/2023)
11/1/2023
  • Motion to Extend Time
STIPULATION to Further Extend Time to answer, move or otherwise respond to the Complaint to December 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 11/1/2023 (nms). (Entered: 11/01/2023)
10/13/2023
  • Answer
Answer to Counterclaims of Defendants Auson Pharmaceuticals Inc. and Auson Pharmaceuticals Co., Ltd. (see D.I. 10 in C.A. No. 23-1103) by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) Modified on 10/13/2023 (nms). (Entered: 10/13/2023)
10/6/2023NOTICE requesting Clerk to remove Ty W. Callahan as co-counsel. Reason for request: No longer with the firm of Wilson Sonsini Goodrich & Rosati. (Palapura, Bindu) (Entered: 10/06/2023)
10/4/2023CASE REFERRED to Magistrate Judge Laura D Hatcher to handle all discovery disputes including any that arise in connection with expert reports. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA(nms) (Entered: 10/04/2023)
10/4/2023Case no longer referred to Judge Jennifer L. Hall for discovery. (nms) (Entered: 10/04/2023)
10/4/2023
  • Order
TRANSFER ORDER - re: pldg. (62 in MDL No. 3017, 24 in NJ/2:23-cv-03020), (49 in MDL No. 3017, 11 in NJ/2:23-cv-03020) Transferring 1 action(s) - MDL No. 3017, NJ/2:23-cv-03020. Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 10/4/2023. (Attachments: # 1 Transferee Letter) (smg) (Entered: 10/04/2023)
10/3/2023
  • Motion to Extend Time
SO ORDERED, re 191 STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint (*Reset Answer Deadlines: FPP Holding Company LLC answer due 11/1/2023; Indoco Remedies Limited answer due 11/1/2023). Signed by Judge Richard G. Andrews on 10/3/2023. (nms) (Entered: 10/03/2023)
10/2/2023
  • Motion to Extend Time
STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/3/2023 (nms). (Entered: 10/02/2023)
9/25/2023
  • Answer
Answer to Counterclaims of Defendant Teva Pharmaceuticals USA, Inc.,filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Blumenfeld, Jack) Modified on 9/25/2023 (nms). (Entered: 09/25/2023)
9/15/2023
  • OrderGranted
SO ORDERED Granting (D.I. 188 in 21-md-3017-RGA; D.I. 16 in 23-cv-551-RGA; D.I. 154 in 21-cv-314-RGA-JLH) Stipulation and Proposed Order Regarding Consolidation and Schedule. Signed by Judge Richard G. Andrews on 9/15/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:23-cv-00551-RGA(nms) (Entered: 09/15/2023)
9/15/2023
  • Motion to Consolidateby Π
STIPULATION and [Proposed] Order Regarding Consolidation and Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/15/2023)
9/8/2023
  • OrderGranted
SO ORDERED Granting (D.I. 13 in 23-cv-410-RGA; D.I. 186 in 21-md-3017-RGA; D.I. 126 in 21-cv-1742-RGA; D.I. 152 in 21-cv-314-RGA-JLH) Stipulation and Proposed Order Regarding Stay. Signed by Judge Richard G. Andrews on 9/8/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:23-cv-00410-RGA(nms) (Entered: 09/08/2023)
9/8/2023
  • Motion to Stayby Π
STIPULATION and [Proposed] Order Regarding Stay - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/08/2023)
9/5/2023
  • Answer
Answer to Counterclaims of Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc., filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/5/2023 (nms). (Entered: 09/05/2023)
9/5/2023Pro Hac Vice Attorneys Rachel L. Schweers and Brian Sodikoff for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 09/05/2023)
9/1/2023
  • Order
SO ORDERED, re (D.I. 184 in 21-md-3017-RGA; D.I. 151 in 21-cv-314-RGA-JLH; D.I. 125 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to file Joint Status Report to September 8, 2023. Signed by Judge Richard G. Andrews on 9/1/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 09/01/2023)
9/1/2023 STIPULATION and Proposed Order to Extend Time to file Joint Status Report to September 8, 2023 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) Modified on 9/1/2023 (nms). (Entered: 09/01/2023)
9/1/2023183
  • Motion to Extend Time
SO ORDERED, re 182 STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to October 2, 2023. Signed by Judge Richard G. Andrews on 9/1/2023. (nms) (Entered: 09/01/2023)
9/1/2023
  • Motion to Extend Time
STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to October 2, 2023 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/1/2023 (nms). (Entered: 09/01/2023)
8/25/2023
  • Order
SO ORDERED, granting (D.I. 150 in 1:21-cv-00314-RGA-JLH, D.I. 124 in 1:21-cv-01742-RGA, D.I. 181 in 1:21-md-03017-RGA) Stipulation and Proposed Order to Extend Time (*reset deadlines: Joint Status Report due by 9/1/2023.) Signed by Judge Richard G. Andrews on 8/25/2023. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(lah) (Entered: 08/25/2023)
8/25/2023 STIPULATION and Proposed Order to Extend Time for the parties to provide a joint status report - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/25/2023 (lah). (Entered: 08/25/2023)
8/16/2023NOTICE of Appearance by John M. Seaman on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Seaman, John) (Entered: 08/16/2023)
8/16/2023NOTICE of Appearance by April M Ferraro on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Ferraro, April) (Entered: 08/16/2023)
8/16/2023Pro Hac Vice Attorney Kiersten A. Fowler for Dr. Reddy's Laboratories, Inc., and Dr. Reddy's Laboratories, Ltd., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-00410-RGA, 1:21-md-03017-RGA(mkr) (Entered: 08/16/2023)
8/16/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Thomson, G.) (Entered: 08/16/2023)
8/16/2023
  • Answer
ANSWER to Complaint and COUNTERCLAIMS against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc..(Thomson, G.) Modified on 8/16/2023 (nms). (Entered: 08/16/2023)
8/16/2023
  • Order
SO ORDERED, re (D.I. 176 in 21-md-3017-RGA; D.I. 12 in 23-cv-410-RGA) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein and Kiersten A. Fowler, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories Ltd.. Signed by Judge Richard G. Andrews on 8/16/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00410-RGA(nms) (Entered: 08/16/2023)
8/16/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein and Kiersten A. Fowler - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Belgam, Neal) (Entered: 08/16/2023)
8/15/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories Ltd. for Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Belgam, Neal) (Entered: 08/15/2023)
8/15/2023
  • Answer
ANSWER to Complaint with Separate Defenses, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Belgam, Neal) Modified on 8/15/2023 (nms). (Entered: 08/15/2023)
8/14/2023
  • Order
SO ORDERED, granting (D.I. 149 in 1:21-cv-00314-RGA-JLH; D.I. 173 in 1:21-md-03017-RGA; D.I. 123 in 1:21-cv-01742-RGA) Stipulation and Proposed Order to Extend Time to provide a Joint Status Report by August 25, 2023, filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG. (*Reset Deadlines: Joint Status Report due by 8/25/2023). Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA, 1:21-cv-01742-RGA. Signed by Judge Richard G. Andrews on 8/14/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(lah) (Entered: 08/14/2023)
8/11/2023 STIPULATION and Proposed Order to Extend Time to provide a Joint Status Report by August 25, 2023, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Main Document 173 replaced on 8/11/2023) (nms). Modified on 8/11/2023 (nms). (Entered: 08/11/2023)
8/10/2023 NOTICE of Service of Change of Address for J.C. Rozendaal, Chandrika Vira, and Brady Gleason of Sterne, Kessler, Goldstein & Fox, P.L.L.C. by Teva Pharmaceuticals USA, Inc. (DiBenedetto, Emily) Modified on 8/15/2023 (nms). (Entered: 08/10/2023)
8/7/2023
  • OrderGranted
SO ORDERED Granting (D.I. 14 in 23-cv-334-RGA; D.I. 170 in 21-md-3017-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc.. Signed by Judge Richard G. Andrews on 8/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00334-RGA(nms) (Entered: 08/07/2023)
8/4/2023
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal between Plaintiff and Defendants Biocon Pharma Limited, Biocon Limited, and Biocon Pharma, Inc., by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 8/7/2023 (nms). (Entered: 08/04/2023)
7/27/2023
  • OrderGranted
SO ORDERED Granting (D.I. 169 in 21md-3017-RGA; D.I. 10 in 23-cv-690-RGA) STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to September 1, 2023. Signed by Judge Richard G. Andrews on 7/27/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00690-RGA(nms) (Entered: 07/27/2023)
7/27/2023
  • Motion to Extend Time
STIPULATION to Extend Time to answer, move or otherwise respond to the Complaint to September 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GmbH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/27/2023 (nms). (Entered: 07/27/2023)
7/21/2023
  • Answerby Π
ANSWER to 165 Answer to Complaint, Counterclaim by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 07/21/2023)
6/30/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp.. (Hitch, Cortlan) (Entered: 06/30/2023)
6/30/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc. filed by Apotex Inc.. (Hitch, Cortlan) (Entered: 06/30/2023)
6/30/2023
  • Answer
ANSWER to Complaint and Counterclaims against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. by Apotex Inc., Apotex Corp..(Hitch, Cortlan) Modified on 6/30/2023 (nms). (Entered: 06/30/2023)
6/22/2023REDACTED VERSION of 157 Letter, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/22/2023 (nms). (Entered: 06/22/2023)
6/21/2023
  • OrderGranted
SO ORDERED Granting (D.I. 161 in 21-md-3017-RGA; D.I. 22 in 22-cv-1492-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 06/21/2023)
6/21/2023
  • Order
SO ORDERED, re (D.I. 10 in 23-cv-327-RGA; D.I. 162 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00327-RGA(nms) (Entered: 06/21/2023)
6/21/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 06/21/2023)
6/20/2023
  • Motion to Dismiss (Demurrer)by Π
STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 06/20/2023)
6/20/2023
  • OrderGranted
SO ORDERED Granting (D.I. 155 in 21-md-3017-RGA; D.I. 146 in 21-cv-314-RGA-JLH; D.I. 18 in 22-cv-1596-RGA) Stipulation and Order Regarding Consolidation and Scheduled. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023)
6/20/2023
  • OrderGranted
SO ORDERED Granting (D.I. 154 in 21-md-3017-RGA; D.I. 17 in 22-cv-1596-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023)
6/16/2023158
  • Motion to File
ORAL ORDER: The request to file another status report by 6/22/2023 (D.I. 20 in 22-cv-1492-RGA; D.I. 157 in 21-md-3017-RGA) is GRANTED. Ordered by Judge Richard G. Andrews on 6/16/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 06/16/2023)
6/15/2023[SEALED] Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 6/16/2023 (nms). (Entered: 06/15/2023)
6/12/2023156
  • Order
ORAL ORDER: Defendant USV Private Limited's answer was due to be filed on 6/8/2023 (see D.I. 153 in MDL 21-3017; D.I. 18 in C.A. 22-1492), and to date none has been filed. A status letter is now due no later than three (3) days from the entry of this Order. Ordered by Judge Richard G. Andrews on 6/12/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 06/12/2023)
6/2/2023 STIPULATION and Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023)
6/2/2023 STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023)
6/1/2023
  • Motion to Extend Time
SO ORDERED, re 153 Unopposed Motion to Extend Time (*Reset Answer Deadlines: USV Private Limited answer due 6/8/2023). Signed by Judge Richard G. Andrews on 6/1/2023. (nms) (Entered: 06/01/2023)
5/31/2023
  • Motion to Extend Time
Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/1/2023 (nms). (Entered: 05/31/2023)
5/3/2023
  • OrderGranted
SO ORDERED Granting (D.I. 151 in 21-md-3017-RGA; D.I. 11 in 23-cv-335-RGA) Stipulation of Dismissal. Signed by Judge Richard G. Andrews on 5/3/2023. Associated Cases: 1:23-cv-00335-RGA, 1:21-md-03017-RGA(nms) (Entered: 05/03/2023)
5/3/2023
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal, by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/3/2023 (nms). (Entered: 05/03/2023)
4/27/2023
  • Motion to Extend Time to Answer
SO ORDERED, re 150 Unopposed Motion to Extend Time to file answer or otherwise respond to June 1, 2023. Signed by Judge Richard G. Andrews on 4/27/2023. (nms) (Entered: 04/27/2023)
4/27/2023
  • Motion to Extend Time
Unopposed Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 4/27/2023 (nms). (Entered: 04/27/2023)
4/12/2023NOTICE of Appearance by Patricia Smink Rogowski on behalf of ScieGen Pharmaceuticals, Inc. (Rogowski, Patricia) (Entered: 04/12/2023)
3/24/2023
  • Order
SO ORDERED, re (D.I. 148 in 21-md-3017-RGA; D.I. 16 in 22-cv-1492-RGA) Unopposed Motion to Extend Time to Answer or otherwise respond to the Complaint to May 1, 2023. Signed by Judge Richard G. Andrews on 3/24/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 03/24/2023)
3/24/2023
  • Motion to Extend Time
UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until to May 1, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 3/24/2023 (nms). (Entered: 03/24/2023)
3/17/2023 NOTICE of Withdrawal of Appearance of Delaware Counsel, Eve Ormerod by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve) (Entered: 03/17/2023)
3/8/2023NOTICE OF SERVICE of (1) Apotex's ANDA Production and (2) Apotex's Core Technical Documents Production filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 03/08/2023)
3/7/2023
  • Order
SO ORDERED, re (D.I. 14 in 22-cv-1596-RGA; D.I. 145 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 3/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) (Entered: 03/07/2023)
3/7/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023)
3/7/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023)
3/7/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceuticals Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023)
3/7/2023
  • Answer
Answer to Complaint, Separate Defenses and Counterclaims, by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) Modified on 3/7/2023 (nms). (Entered: 03/07/2023)
2/28/2023
  • Order
SO ORDERED, re ( D.I. 15 in 22-cv-1492-RGA; D.I. 141 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023. Signed by Judge Richard G. Andrews on 2/28/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 02/28/2023)
2/28/2023
  • Motion to Extend Time
UNOPPOSED Motion to Extend Time to answer or otherwise respond to the Complaint until March 30, 2023 - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/28/2023 (nms). (Entered: 02/28/2023)
2/1/2023 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc.; Corporate Parent Viatris Inc. for Mylan Inc. filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 02/01/2023)
1/31/2023
  • Order
SO ORDERED, re (D.I. 139 in 21-md-3017-RGA; D.I. 14 in 22-cv-1492-RGA) Unopposed Motion for Extension of Time to answer or otherwise respond to the Complaint until 2/28/2023. Signed by Judge Richard G. Andrews on 1/31/2023. Associated Cases: 1:22-cv-01492-RGA, 1:21-md-03017-RGA(nms) (Entered: 01/31/2023)
1/31/2023
  • Motion to Extend Time
Unopposed Motion for Extension of Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/31/2023 (nms). (Entered: 01/31/2023)
1/18/2023Case Stayed see Order at D.I. 138 . (nms) (Entered: 03/24/2025)
1/18/2023Minute Entry for proceedings held before Judge Richard G. Andrews - Hearing on the Motion to Extend Schedule held on 1/18/2023. Counsel for Plaintiffs: D. Fahnestock. Counsel for Defendants: N. Hoeschen, M. Haney, N. Belgam, R. Vrana, D. Moore. No later than 14 days after the PTAB decision, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. (Court Reporter Heather Triozzi.) Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(lah) (Entered: 01/18/2023)
1/18/2023138
  • Order
ORAL ORDER: For the reasons stated on the record on January 18, 2023, a stay of the case is GRANTED until fourteen days after the PTAB issues a final written decision on the related IPR. At that time, the parties are to submit a joint status report with a proposed schedule resulting in a trial date in January or February 2024. The motion to extend schedule (D.I. 125) is DISMISSED as moot. Ordered by Judge Richard G. Andrews on 1/18/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 01/18/2023)
1/6/2023137
  • Order
ORAL ORDER: A hearing on the Motion to Extend Schedule (D.I. 134 in 21-cv-314-RGA-JLH; D.I. 113 in 21-cv-1742-RGA; D.I. 125 in 21-md-3017-RGA) is now set for 1/18/2023, at 10:00 AM in Courtroom 6A. Ordered by Judge Richard G. Andrews on 1/6/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 01/06/2023)
1/5/2023
  • Order
SO ORDERED, Granting (D.I. 12 in 22-cv-1492-RGA; D.I. 136 in 21-md-3017-RGA) Unopposed Motion to Extend Time to answer or otherwise respond to Complaint to January 31, 2023. Signed by Judge Richard G. Andrews on 1/5/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 01/05/2023)
1/4/2023
  • Motion to Extend Time
UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 1/5/2023 (nms). (Entered: 01/04/2023)
1/3/2023 Letter to The Honorable Richard G. Andrews, from Emily S. DiBenedetto, regarding request for oral argument. (DiBenedetto, Emily) Modified on 1/4/2023 (nms). (Entered: 01/03/2023)
12/27/2022
  • Reply
REPLY Brief in further support to 125 MOTION to Extend Case Schedule, filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Hoeschen, Nathan) Modified on 12/28/2022 (nms). (Entered: 12/27/2022)
12/16/2022 ANSWERING BRIEF in Opposition re 125 MOTION to Extend Schedule, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 12/27/2022. (Fahnestock, Derek) Modified on 12/16/2022 (nms). (Entered: 12/16/2022)
12/14/2022NOTICE of Appearance by James S. Green, Jr on behalf of USV Private Limited (Green, James) (Entered: 12/14/2022)
12/14/2022 NOTICE of Withdrawal of Motion to Extend Schedule (D.I. 125 ), by Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s. (Ormerod, Eve) Modified on 12/14/2022 (nms). Modified on 12/15/2022 (nms). (Entered: 12/14/2022)
12/13/2022
  • Order
SO ORDERED, re (D.I. 137 in 21-cv-314-RGA-JLH; D.I. 116 in 21-cv-1742-RGA, D.I. 129 in 21-md-03017-RGA) Stipulation and Proposed Order to Extend Schedule. Signed by Judge Richard G. Andrews on 12/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 12/13/2022)
12/13/2022
  • Order
SO ORDERED, re (D.I. 130 in 21-md-3017-RGA; D.I. 138 in 21-cv-314-RGA-JLH; D.I. 117 in 21-cv-01742-RGA) STIPULATION and Proposed order to Extend Time to file response to Defendants' Motion to Extend Schedule to December 16, 2022. Signed by Judge Richard G. Andrews on 12/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 12/13/2022)
12/13/2022STIPULATION and Proposed Order to Extend Time to file their response to Defendants' Motion to Extend Schedule - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/13/2022 (nms). (Entered: 12/13/2022)
12/13/2022 STIPULATION and [Proposed] Order to Extend Schedule - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 12/13/2022)
12/5/2022
  • Order
SO ORDERED, re (D.I. 10 in 22-cv-1492-RGA; D.I. 128 in 21-md-3017-RGA) UNOPPOSED Motion to Extend Time to answer the complaint to 1/5/2023. Signed by Judge Richard G. Andrews on 12/5/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01492-RGA(nms) (Entered: 12/05/2022)
12/5/2022
  • Motion to Extend Time
UNOPPOSED Motion to Extend Time - filed by Bayer AG, Bayer Intellectual Property GMBH, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/5/2022 (nms). (Entered: 12/05/2022)
12/2/2022NOTICE OF SERVICE of (1) Plaintiff Bayer's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) and (2) Plaintiff Janssen's Objections and Responses to Defendants' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 12/02/2022)
12/1/2022
  • Order
SO ORDERED, re (D.I. 126 in 21-md-3017-RGA; D.I. 114 in 21-cv-1742-RGA; D.I. 135 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/1/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 12/01/2022)
12/1/2022
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Susannah M. L. Gagnon of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 12/01/2022)
11/29/2022Set Answering Brief Deadline re 125 MOTION to Extend Schedule. Answering Brief/Response due date per Local Rules is 12/13/2022. (nms) (Entered: 11/30/2022)
11/29/2022
  • Motion
MOTION to Extend Schedule - filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 11/29/2022 (nms). (Entered: 11/29/2022)
11/29/2022CORRECTING ENTRY: The motion to extend schedule filed on 11/28/2022, has been removed from the docket. The filer requested this as an amended motion will be refiled. Associated Cases: 1:21-cv-01742-RGA, 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 11/29/2022)
11/16/2022
  • OrderGranted
SO ORDERED Granting (D.I. 123 in 21-md-3017-RGA; D.I.132 in 21-cv-314-RGA-JLH) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 11/16/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 11/16/2022)
11/16/2022 STIPULATION and Order regarding Infringement by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/16/2022)
11/14/2022NOTICE requesting Clerk to remove David M. Knapp as co-counsel.. (Vrana, Robert) (Entered: 11/14/2022)
11/14/2022
  • Order
CONDITIONAL TRANSFER ORDER FINALIZED (CTO-2) - 1 action(s) re: pldg. (35 in MDL No. 3017, 2 in NJ/2:22-cv-05485) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 11/14/2022. (Attachments: # 1 Transferee Letter) (smg) (Entered: 11/14/2022)
11/11/2022 NOTICE of Change of Firm Affiliation by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert) (Entered: 11/11/2022)
11/7/2022
  • Motionby Π
STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Mylan Pharmaceutical Inc. and Mylan Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 11/07/2022)
11/2/2022NOTICE to Take Deposition of Janssen Pharmaceuticals, Inc. filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022)
11/2/2022NOTICE to Take Deposition of Bayer Pharma AG and Bayer AG filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022)
11/2/2022NOTICE to Take Deposition of Frank Misselwitz filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022)
11/2/2022NOTICE to Take Deposition of Nancy Cook Bruns filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 11/02/2022)
10/20/2022NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) (Entered: 10/20/2022)
10/19/2022
  • OrderGranted
SO ORDERED Granting (D.I. 123 in 21-cv-314-RGA-JLH; D.I. 112 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/19/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 10/19/2022)
10/18/2022 STIPULATION and Order Regarding Infringement (as to Defendants Lupin Limited and Lupin Pharmaceutical, Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 10/18/2022)
10/18/2022NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s Identification References & Combinations filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Belgam, Neal) (Entered: 10/18/2022)
10/18/2022
  • OrderGranted
SO ORDERED Granting (D.I. 107 in 21-md-3017-RGA; D.I. 39 in 22-cv-1228-RGA; D.I. 104 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order Consolidating Cases and Adopting Schedule. Signed by Judge Richard G. Andrews on 10/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA, 1:22-cv-01228-RGA(nms) (Entered: 10/18/2022)
10/18/2022NOTICE OF SERVICE of Defendants' Disclosure Pursuant to Paragraph 4(g)(iii) of the Scheduling Order filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 10/18/2022)
10/17/2022NOTICE OF SERVICE of Defendants' Prior Art Narrowing Disclosure (also filed on behalf of Defendant Teva Pharmaceuticals USA, Inc.) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/17/2022)
10/17/2022
  • Motion to Consolidate
Joint Stipulation and [Proposed] Order Consolidating Cases and Adopting Schedule, by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/18/2022 (nms). (Entered: 10/17/2022)
10/17/2022 NOTICE of Withdrawal of Defendants' Motion to Dismiss by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) Modified on 10/17/2022 (nms). (Entered: 10/17/2022)
10/12/2022REDACTED VERSION of 99 Answering Brief in Opposition, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Fahnestock, Derek) Modified on 10/12/2022 (nms). (Entered: 10/12/2022)
10/12/2022
  • OrderGranted
SO ORDERED Granting (D.I. 117 in 21-cv-314-RGA-JLH; D.I. 102 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 10/12/2022)
10/11/2022
  • OrderGranted
SO ORDERED Granting (D.I. 116 in 21-cv-314-RGA-JLH; D.I. 101 in 21-md-3017-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 10/11/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 10/11/2022)
10/11/2022
  • Motionby Π
STIPULATION and [Proposed] Order Regarding Infringement (as to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.) - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 10/11/2022)
10/7/2022 STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 10/11/2022 (nms). (Entered: 10/07/2022)
10/3/2022
  • Answer
ANSWER to Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Fahnestock, Derek) Modified on 10/3/2022 (nms). (Entered: 10/03/2022)
10/3/2022
  • Motion to Dismiss (Demurrer)
[SEALED] ANSWERING BRIEF in Opposition re Motion to Dismiss (D.I. 25 in C.A. 22-1228-RGA), filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Reply Brief due date per Local Rules is 10/11/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Fahnestock, Derek) Modified on 10/3/2022 (nms). (Entered: 10/03/2022)
9/30/2022
  • Order
SO ORDERED, re (D.I. 98 in 21-md-3017-RGA; D.I. 115 in 21-cv-314-RGA-JLH; D.I. 103 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 9/30/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 09/30/2022)
9/30/2022
  • Motion to Extend Time
Joint Stipulation and [Proposed] Order to Extend Time, by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) Modified on 9/30/2022 (nms). (Entered: 09/30/2022)
9/23/2022
  • Order
SO ORDERED, re (D.I. 97 in 21-md-3017-RGA; D.I. 34 in 22-cv-1228-RGA) STIPULATION and Proposed Order to Extend Time to respond to Motion to Dismiss and to file reply brief to October 3, 2022, and October 17, 2022. Signed by Judge Richard G. Andrews on 9/23/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01228-RGA(nms) (Entered: 09/23/2022)
9/23/2022
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME (1) for Plaintiffs Bayer Pharma AG, Bayer AG, and Janssen Pharmaceuticals, Inc. to respond to Defendants' Motion to Dismiss (D.I. 25); and (2) for Defendants to file their reply brief to October 3, 2022, and October 17, 2022, respectively - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 09/23/2022)
9/21/2022
  • Order
CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) - 1 action(s) re: pldg. (29 in MDL No. 3017, 1 in WVN/1:22-cv-00063) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel John W. Nichols on 9/21/2022. (Attachments: # 1 Transferee Letter) (smg) (Entered: 09/21/2022)
9/19/2022NOTICE to Take Deposition of Wayne Talton on October 14, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Kristen McElwayne on October 13, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Beth Britton on October 6, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Natalie Yantovskiy on October 19, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Miriam Getsis on October 12, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Avi Avramoff on October 5, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Makrand Avichat on October 18, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Pramod Dahibhate on October 11, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Jason Gensburger on October 4, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Srinivasa Rao on October 17, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Sowjanya Madala on October 10, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/19/2022NOTICE to Take Deposition of Shobha Chagam on October 3, 2022 filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/19/2022)
9/12/2022NOTICE OF SERVICE of (1) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.; (2) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.; (3) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.; and (4) Plaintiffs' Identification of No More Than Four Asserted Claims to Defendant Teva Pharmaceuticals USA, Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/12/2022)
9/12/2022NOTICE OF SERVICE of Plaintiffs' Identification of No More Than Four Asserted Claims to Defendants Mylan Pharmaceuticals Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 09/12/2022)
9/9/2022
  • Order
SO ORDERED, re (D.I. 81 in 21-md-3017-RGA; D.I. 98 in 21-cv-1742-RGA; D.I. 104 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers, filed by Bayer Pharma AG, Bayer AG. Signed by Judge Richard G. Andrews on 9/9/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 09/09/2022)
9/9/2022
  • Motion to Appear Pro Hac Viceby Π
MOTION for Pro Hac Vice Appearance of Attorney Seth R. Bowers - filed by Bayer AG, Bayer Pharma AG. (Fahnestock, Derek) (Entered: 09/09/2022)
9/9/2022NOTICE OF SERVICE of Defendants Dr. Reddys Laboratories, Inc. and Dr. Reddys Laboratories, Ltd.'s First Supplemental Objections and Responses to Plaintiffs Bayer Pharma AG and Janssen Pharmaceuticals, Inc.s First Joint Set of Interrogatories filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) (Entered: 09/09/2022)
9/8/2022
  • Order
SO ORDERED, re (D.I. 102 in 21-cv-314-RGA-JLH; D.I. 97 in 21-cv-1742-RGA; D.I. 79 in 21-md-3017-RGA) STIPULATION to Extend Time to substantially complete document production to September 23, 2022. Signed by Judge Richard G. Andrews on 9/8/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 09/08/2022)
9/8/2022
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 09/08/2022)
9/8/2022
  • Order
SO ORDERED, re (D.I. 78 in 21-md-3017-RGA; D.I. 101 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 9/8/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 09/08/2022)
9/8/2022
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) (Entered: 09/08/2022)
9/7/2022NOTICE to Take Deposition of Teva Pharmaceuticals USA, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022)
9/7/2022NOTICE to Take Deposition of Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022)
9/7/2022NOTICE to Take Deposition of Lupin Limited and Lupin Pharmaceuticals, Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022)
9/7/2022NOTICE to Take Deposition of Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 09/07/2022)
9/7/2022NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. and Mylan Inc. on a date mutually agreeable to the parties filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc..(Fahnestock, Derek) (Entered: 09/07/2022)
8/30/2022NOTICE of Change of Address by Megan C. Haney (Haney, Megan) (Entered: 08/30/2022)
8/24/202271
  • Order
SO ORDERED, re (D.I. 94 in 21-cv-1742-RGA; D.I. 70 in 21-md-3017-RGA; 94 in 21-cv-314-RGA-JLH) STIPULATION to Extend Time for Plaintiffs and Defendants to substantially complete document production to September 9, 2022. Signed by Judge Richard G. Andrews on 8/24/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 08/24/2022)
8/24/2022
  • Motion to Extend Timeby Π
STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production to September 9, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 08/24/2022)
8/5/2022NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) and (2) Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production to Plaintiffs (Nos. 1-2) - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 08/05/2022)
7/27/2022
  • Order
SO ORDERED, re (D.I. 68 in 21-md-3017-RGA; D.I. 92 in 21-cv-314-RGA-JLH; D.I.93 in 21-cv-1742-RGA) Joint Stipulation and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 7/27/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 07/27/2022)
7/26/2022
  • Motion to Extend Timeby Δ
Joint STIPULATION TO EXTEND TIME for Plaintiffs and Defendants to substantially complete document production shall be extended from August 5, 2022 to allow the parties additional time to search for and produce documents to August 26, 2022 - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) (Entered: 07/26/2022)
7/12/2022
  • OrderGranted
SO ORDERED Granting (D.I. 66 in 21-md-3017-RGA; D.I. 90 in 21-cv-314-RGA-JLH) Stipulation of Dismissal (*Micro Labs USA, Inc. and Micro Labs Limited terminated). Signed by Judge Richard G. Andrews on 7/12/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 07/12/2022)
7/6/2022
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal with prejudice, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 7/7/2022 (nms). (Entered: 07/06/2022)
7/6/2022NOTICE OF SERVICE of Lupin's First Set of Requests for Production to Plaintiffs (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 07/06/2022)
7/1/2022
  • Order
SO ORDERED, re (D.I. 88 in 21-cv-314-RGA-JLH; D.I. 64 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order (between Plaintiffs and Defendants "Micro"). Signed by Judge Richard G. Andrews on 7/1/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 07/01/2022)
7/1/2022STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Hitch, Cortlan) Modified on 7/1/2022 (nms). (Entered: 07/01/2022)
6/27/2022
  • OrderGranted
SO ORDERED Granting (D.I. 62 in 21-md-3017-RGA: D.I. 86 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/27/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 06/27/2022)
6/24/2022 STIPULATION Amend Scheduling Order as to Plaintiffs and Micro Labs by Micro Labs Ltd.. (Hitch, Cortlan) (Entered: 06/24/2022)
6/10/2022
  • Order
SO ORDERED, re (D.I. 61 in 21-md-3017-RGA; D.I. 85 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 6/10/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 06/10/2022)
6/10/2022
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Louis H. Weinstein - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) (Entered: 06/10/2022)
6/9/2022 NOTICE of Withdrawal of Appearance of Anandita Vyakarnam by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc. (Ormerod, Eve) (Entered: 06/09/2022)
6/8/2022NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s 1) Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) and 2) Responses and Objections to Plaintiffs' First Joint Set of Interrogatories (Nos. 1-7) filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) (Entered: 06/08/2022)
6/7/2022NOTICE OF SERVICE of 1) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Joint Set of Interrogatories; and 2) Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Response to Plaintiffs' First Set of Requests for Production filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) (Entered: 06/07/2022)
6/7/2022NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Joint Set Of Interrogatories (Nos. 1-7), and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Objections And Responses To Plaintiffs' First Set Of Requests For Production (Nos. 1-43) filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 06/07/2022)
6/7/2022NOTICE OF SERVICE of 1. Teva's Objections and Responses to Plaintiffs' First Set of Interrogatories 2. Teva's Objections and Responses to Plaintiffs' First Set of Requests for Production (Nos. 1 - 43) filed by Taro Pharmaceuticals U.S.A., Inc., Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) (Entered: 06/07/2022)
6/6/2022NOTICE OF SERVICE of Lupin's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) and Lupin's Responses and Objections to Plaintiffs' First Set of Requests for Production (Nos. 1-43) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Haney, Megan) (Entered: 06/06/2022)
6/2/202254
  • Order
SO ORDERED, re (D.I. 77 in 21-cv-314-RGA-JLH; D.I. 53 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 6/2/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 06/02/2022)
6/2/2022 STIPULATION to Amended Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) (Entered: 06/02/2022)
6/1/2022NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); (2) Plaintiffs Bayer Pharma AG and Bayer AG's Responses to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9); (3) Plaintiff Janssen Pharmaceutical Inc.'s Responses and Objections to Defendants' First Set of Joint Requests for Production (Nos. 1-60); and (4) Plaintiff Janssen Pharmaceuticals, Inc.'s Responses and Objections to Defendants' First Set of Joint Interrogatories to Plaintiffs (Nos. 1-9) filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 06/01/2022)
6/1/2022Pro Hac Vice Attorney Frank D. Rodriguez for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/01/2022)
5/31/2022
  • Order
SO ORDERED, re (D.I. 51 in 21-md-3017-RGA; D.I. 75 in 21-cv-314-RGA-JLH) MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez, filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 5/31/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 05/31/2022)
5/31/2022
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez - filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.. (Ormerod, Eve) (Entered: 05/31/2022)
5/25/2022Pro Hac Vice Attorney David M. Knapp for Taro Pharmaceutical Industries, Ltd. and Taro Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 05/25/2022)
5/25/2022
  • Order
SO ORDERED, re (D.I. 74 in 21-cv-314-RGA-JLH; D.I. 50 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp, filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 5/25/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 05/25/2022)
5/24/2022
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney David M. Knapp - filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Vrana, Robert) (Entered: 05/24/2022)
5/24/202249
  • OrderGranted
SO ORDERED Granting (D.I. 89 in 21-cv-1742-RGA; D.I. 72 in 21-cv-314-RGA-JLH; D.I. 48 in 21-md-3017-RGA) Stipulation and Proposed Order regarding claim construction (*The Markman hearing scheduled for 8/23/2022 is CANCELED). Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 05/24/2022)
5/24/2022
  • Motion for Claim Construction
STIPULATION and [Proposed] Order regarding claim construction, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 5/24/2022 (nms). (Entered: 05/24/2022)
5/24/2022
  • Order
SO ORDERED, re (D.I. 71 in 21-cv-314-RGA-JLH; D.I. 47 in 21-md-3017-RGA; D.I. 88 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time to Submit Joint Claim Construction Chart to May 24, 2022. Signed by Judge Richard G. Andrews on 5/24/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 05/24/2022)
5/23/2022 STIPULATION TO EXTEND TIME to Submit Joint Claim Construction Chart to May 24, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Haney, Megan) (Entered: 05/23/2022)
5/23/2022
  • Order
SO ORDERED, re (D.I. 46 in 21-md-3017-RGA; D.I. 70 in 21-cv-314-RGA-JLH) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/23/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 05/23/2022)
5/23/2022 STIPULATION to Amend the Scheduling Order by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) (Entered: 05/23/2022)
5/20/2022
  • Order
SO ORDERED, re (D.I. 45 in 21-md-3017-RGA; D.I. 69 in 21-cv-314-RGA-JLH; D.I. 87 in 21-cv-1742-RGA) STIPULATION and Proposed Order to Extend Time for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022. Signed by Judge Richard G. Andrews on 5/20/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 05/20/2022)
5/19/2022 STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 23, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 05/19/2022)
5/18/2022
  • OrderGranted
SO ORDERED Granting (D.I. 84 in 21-cv-1742-RGA; D.I. 42 in 21-md-3017-RGA) Stipulation Amending Order. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 05/18/2022)
5/18/2022
  • Order
SO ORDERED, re (D.I. 85 in 21-cv-1742-RGA; D.I. 68 in 21-cv-314-RGA-JLH; D.I. 43 in 21-md-3017-RGA) STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing. Signed by Judge Richard G. Andrews on 5/18/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 05/18/2022)
5/17/2022STIPULATION and Proposed Order to Extend Time for deadlines related to claim construction briefing - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). (Entered: 05/17/2022)
5/17/2022 STIPULATION Amending Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc.. (Fahnestock, Derek) Modified on 5/18/2022 (nms). (Entered: 05/17/2022)
5/13/2022
  • Order
SO ORDERED, re (D.I. 83 in 21-cv-1742-RGA; D.I. 41 in 21-md-3017-RGA; D.I. 67 in 21-cv-314-RGA-JLH) STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:21-cv-01742-RGA(nms) (Entered: 05/13/2022)
5/13/2022 STIPULATION TO EXTEND TIME for submission of the Joint Claim Construction Chart and associated patents and intrinsic evidence to May 17, 2022 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 05/13/2022)
5/13/2022
  • Order
SO ORDERED, re (D.I. 66 in 21-cv-314-RGA-JLH; D.I. 40 in 21-md-3017-RGA) STIPULATION to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 5/13/2022. Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-md-03017-RGA(nms) (Entered: 05/13/2022)
5/13/2022
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME various dates to dates listed in stipulation - filed by Micro Labs Ltd., Micro Labs USA Inc., Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth) (Entered: 05/13/2022)
5/2/2022NOTICE OF SERVICE of Defendants' Identification of Claim Terms and Constructions filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 05/02/2022)
5/2/2022 NOTICE of Change of Address for Williams & Connolly LLP by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc. (Fahnestock, Derek) (Entered: 05/02/2022)
4/29/2022SO ORDERED, re 36 Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/29/2022. (nms) (Entered: 05/02/2022)
4/29/2022NOTICE OF SERVICE of Plaintiffs' Claim Construction Issue Identification - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 04/29/2022)
4/29/2022 STIPULATION to Amended Scheduling Order (between Plaintiffs and Micro Labs), by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) Modified on 4/29/2022 (nms). (Entered: 04/29/2022)
4/22/2022NOTICE OF SERVICE of (1) Plaintiffs' First Joint Set of Interrogatories to Defendants, (2) Plaintiffs' First Set of Requests for Production to Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd., (3) Plaintiffs' First Set of Requests for Production to Defendants Lupin Limited and Lupin Pharmaceuticals, Inc., (4) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (5) Plaintiffs' First Set of Requests for Production to Defendants Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc., (6) Plaintiffs' First Set of Requests for Production to Defendants Micro Labs Ltd. and Micro Labs USA, Inc., and (7) Plaintiffs' First Set of Requests for Production to Defendants Mylan Pharmaceuticals, Inc. and Mylan Inc. - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 04/22/2022)
4/18/2022NOTICE OF SERVICE of Defendants' First Set Of Joint Interrogatories To Plaintiffs (Nos. 1-9); and Defendants' First Set Of Joint Requests For Production To Plaintiffs (Nos. 1-60) filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 04/18/2022)
4/18/2022
  • Order
SO ORDERED, re (D.I. 59 in 21-cv-314-RGA-JLH; D.I. 33 in 21-md-3017-RGA) Stipulation to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 4/18/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH(nms) (Entered: 04/18/2022)
4/18/2022 STIPULATION to Amend the Scheduling Order (between Plaintiffs and Micro Labs) by Micro Labs Ltd., Micro Labs USA Inc.. (Dorsney, Kenneth) (Entered: 04/18/2022)
4/15/2022NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery and (2) Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delawares Default Standard for Discovery - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 04/15/2022)
4/5/2022NOTICE OF SERVICE of (1) Micro Labs' Rule 26(a)(1) Initial Disclosures; and (2) Micro Labs' Paragraph 3 Disclosures filed by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth) (Entered: 04/05/2022)
4/1/2022NOTICE OF SERVICE of (1) Bayer Pharma AG and Bayer AG's Initial Disclosures, (2) Janssen Pharmaceuticals, Inc.'s Initial Disclosures, and (3) Bayer Pharma AG, Bayer AG's, and Janssen Pharmaceuticals, Inc.'s Initial Identification of Asserted Patents and Accused Products and Methods - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 04/01/2022)
3/28/2022
  • Answer
Answer to Counterclaims of Defendants Micro Labs Ltd. and Micro Labs USA, Inc. (see C.A. 22-165-RGA, D.I. 10), by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 3/28/2022 (nms). (Entered: 03/28/2022)
3/22/2022
  • Scheduling Order
SCHEDULING ORDER: Civil Action No. 22-165-RGA is consolidated for all purposes, including trial, with Civil Action 21-314-RGA, and all papers shall be filed in Civil Action No. 21-314-RGA. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 7/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A 2 day Bench Trial is set to start 5/30/2023, at 8:30 AM in Courtroom 6A. Signed by Judge Richard G. Andrews on 3/22/2022. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-00165-RGA(nms) (Entered: 03/22/2022)
3/21/2022 PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 3/21/2022 (nms). (Entered: 03/21/2022)
3/8/2022 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Micro Labs Ltd. for Micro Labs USA, Inc. filed by Micro Labs Limited, Micro Labs USA, Inc.. (Dorsney, Kenneth) (Entered: 03/08/2022)
3/8/2022
  • Answer
ANSWER to Complaint and COUNTERCLAIM against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Micro Labs Limited, Micro Labs USA, Inc..(Dorsney, Kenneth) Modified on 3/9/2022 (nms). (Entered: 03/08/2022)
3/2/2022NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) (Entered: 03/02/2022)
3/2/2022NOTICE of Appearance by David Ellis Moore on behalf of Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc. (Moore, David) (Entered: 03/02/2022)
3/1/2022NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions with Ex. A filed by Mylan Inc., Mylan Pharmaceuticals Inc., Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 03/01/2022)
1/31/2022NOTICE of Appearance by Bindu Ann George Palapura on behalf of Mylan Inc., Mylan Pharmaceuticals Inc. (Palapura, Bindu) (Entered: 01/31/2022)
1/31/2022
  • Order
ORDER ADOPTING SCHEDULE: The 314 Scheduling Order shall govern in this Action as if entered in this action, except that paragraphs 14-16 pertaining to the pretrial and trial shall not be applicable. Signed by Judge Richard G. Andrews on 1/31/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) (Entered: 01/31/2022)
1/31/2022
  • Motion
PROPOSED Order Adopting Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Letter)(Fahnestock, Derek) Modified on 1/31/2022 (nms). (Entered: 01/31/2022)
1/28/2022NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Teva's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 01/28/2022)
1/28/2022NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Taro's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 01/28/2022)
1/28/2022NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Mylan's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 01/28/2022)
1/28/2022NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for Lupin's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 01/28/2022)
1/28/2022NOTICE OF SERVICE of Plaintiffs' Initial Claim Charts for DRL's ANDA Product filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 01/28/2022)
1/25/202213
  • Order
ORAL ORDER: The parties are requested to jointly submit a proposed order formally adopting the schedule already in place for related consolidated civil action 21-314-RGA. The proposed order is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/25/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) (Entered: 01/25/2022)
1/18/2022Joint Letter to The Honorable Richard G. Andrews, from Derek J. Fahnestock, regarding status. (Fahnestock, Derek) Modified on 1/18/2022 (nms). (Entered: 01/18/2022)
1/12/202211
  • Order
ORAL ORDER: A joint status letter is due no later than five (5) days from the date of this Order. Ordered by Judge Richard G. Andrews on 1/12/2022. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-01742-RGA(nms) (Entered: 01/12/2022)
12/29/2021NOTICE OF SERVICE of Mylan Pharmaceuticals Inc. And Mylan Inc.'s Disclosures Pursuant To Paragraph 3 Of The Delaware Default Standard Of Discovery; and Mylan Pharmaceuticals Inc. And Mylan Inc.'s Production Of Core Technical Documents Pursuant To Paragraph 4(b) Of Delawares Default Standard For Discovery [CONFIDENTIAL] filed by Mylan Inc., Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 12/29/2021)
12/29/2021NOTICE OF SERVICE of Janssen Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 12/29/2021)
12/29/2021NOTICE OF SERVICE of Bayer Pharma AG and Bayer AG's Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by Bayer AG, Bayer Pharma AG.(Fahnestock, Derek) (Entered: 12/29/2021)
12/29/2021NOTICE OF SERVICE of Defendants Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd.'s Default Standard Paragraph 3 and 4(b) Disclosures filed by Dr. Reddy's Laboratories Inc., Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc..(Ormerod, Eve) (Entered: 12/29/2021)
12/29/2021NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery and Lupin Limited and Lupin Pharmaceuticals, Inc.'s Production of Documents Pursuant to Paragraph 4(b) of the Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Phillips, John) (Entered: 12/29/2021)
12/29/2021Pro Hac Vice Attorneys Wendy L. Devine, Elham F. Steiner, and Ty W. Callahan for Mylan Inc. and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) (Entered: 12/29/2021)
12/28/2021
  • Order
SO ORDERED, re (D.I. 5 in 21-md-3017-RGA,; D.I. 69 in 21-cv-1742-RGA) MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati, filed by Mylan Inc., Mylan Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 12/28/2021. Associated Cases: 1:21-cv-01742-RGA, 1:21-md-03017-RGA(nms) (Entered: 12/28/2021)
12/28/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Wendy Devine, Elham F. Steiner, and Ty W. Callahan of Wilson Sonsini Goodrich and Rosati - filed by Mylan Inc., Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 12/28/2021)
12/27/2021NOTICE OF SERVICE of 1) Initial Disclosures of Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc. Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Taro Pharmaceutical Industries Ltd and Taro Pharmaceuticals U.S.A. Inc.'s core technical documents filed by Taro Pharmaceutical Industries, Ltd., Taro Pharmaceuticals U.S.A., Inc..(Vrana, Robert) (Entered: 12/27/2021)
12/17/2021
  • Answer
ANSWER to Answer to Complaint and Counterclaim, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 12/20/2021 (nms). (Entered: 12/17/2021)
12/16/2021 NOTICE of Dismissal Without Prejudice of Taro's Counterclaims as to U.S. Patent 9,415,053 by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. (Vrana, Robert) (Entered: 12/16/2021)
12/15/2021Remark: The following cases in the District of Delaware are included in this MDL: 21-cv-314, 21-cv-732, 21-cv-1000, 21-cv-1001, 21-cv-1742. (nmg) (Entered: 12/15/2021)
12/15/2021NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg) (Entered: 12/15/2021)
12/15/2021NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg) (Entered: 12/15/2021)
12/15/2021CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg) (Entered: 12/15/2021)